Dec 30 OPKO Health Inc said on Friday its experimental drug for growth hormone deficiency did not provide a statistically significant benefit over a placebo in a late-stage study.
The drug, hGH-CTP, is being developed in collaboration with Pfizer Inc.
Growth hormone deficiency is a rare disorder characterized by the inadequate secretion of the growth hormone.
(Reporting by Divya Grover in Bengaluru)
British Airways suffers flight delays after global IT outage
LONDON, May 27 British Airways flights in Britain were being delayed and passengers were suffering long waits at airports on Saturday because of a global system outage, the airline said.